Leronlimab (PRO 140) is a humanized Reduced the volume of pulmonary metastases at 8 weeks.
[1]. Jiao X, et al. Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy. Breast Cancer Res. 2021 Jan 23;23(1):11.
















